Showing results (11-20 of 174) with videos related to
Sort By:
Pageof 18
Blood|December 29, 2018
A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chainIvan Ivanov, Anton Matafonov, Mao-Fu Sun, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 2016
Factor XI as a Therapeutic TargetDavid Gailani, Andras GruberExpert Review of Cardiovascular Therapy|July 4, 2007
Role of Factor XII in hemostasis and thrombosis: clinical implicationsThomas Renné, David GailaniCurrent Opinion in Hematology|August 3, 2020
The rebirth of the contact pathway: a new therapeutic targetPriyanka Srivastava, David GailaniBlood|December 24, 2023
Targeting factor XI and factor XIa to prevent thrombosisDavid Gailani, Andras GruberSeminars in Thrombosis and Hemostasis|September 13, 2017
Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial SurfacesBenjamin Tillman, David GailaniJournal of Thrombosis and Haemostasis : JTH|November 4, 2021
A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitorsOphira Salomon, David GailaniArteriosclerosis, Thrombosis, and Vascular Biology|October 6, 2007
Intrinsic pathway of coagulation and arterial thrombosisDavid Gailani, Thomas RennéBlood|January 31, 2022
A mechanism for hereditary angioedema caused by a lysine 311-to-glutamic acid substitution in plasminogenS Kent Dickeson, Sunil Kumar, Mao-Fu Sun, et al.Hematology/Oncology Clinics of North America|September 18, 2016
The Intrinsic Pathway of Coagulation as a Target for Antithrombotic TherapyAllison P Wheeler, David GailaniPageof 18